The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

The risk for those outcomes, as well as for heart attack, “was at least two to three times higher in patients with a ...

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...

INTRODUCTION. RESPIRATORY SYNCYTIAL VIRUS (RSV) is a pneumovirus frequently associated with respiratory illnesses. 1-3 While RSV has been known to cause serious complications in infants and young ...

In 2023, Taiwan’s premature birth rate was 10.88%, meaning about one in 10 newborns was born before 37 weeks of gestation.

RSV primarily affects children and older adults, and can lead to severe illness or death. Severe illness from respiratory syncytial virus (RSV) can be prevented by administration of prophylactic ...